Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Difluprednate Dosing for Post-Phacoemulsification Inflammation
NCT05649111Phase 4Unknown
- Sponsor
- Kafrelsheikh University
- Start
- Nov 2022
- Primary completion
- Feb 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of difluprednate in post-operative inflammation, sponsored by Kafrelsheikh University. Status: unknown.
02
Drugs
difluprednate
03
Conditions
post-operative inflammation
Beyond the preview
Go deeper on NCT05649111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05649111.